Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.

Chen, Bao-Shi; Wang, Kuan-Yu; Yu, Shu-Qing; Zhang, Chuan-Bao; Li, Guan-Zhang; Wang, Zhi-Liang; Bao, Zhao-Shi

Chen, Bao-Shi; Wang, Kuan-Yu; Yu, Shu-Qing; Zhang, Chuan-Bao; Li, Guan-Zhang; Wang, Zhi-Liang; Bao, Zhao-Shi.

Afiliação

Chen BS; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.
Wang KY; Department of Gamma Knife Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.
Yu SQ; Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing 100069, P.R. China.
Zhang CB; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, P.R. China.
Li GZ; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.
Wang ZL; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.
Bao ZS; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, P.R. China.

Oncol Lett ; 20(5): 187, 2020 Nov.

Article em En | MEDLINE | ID: mdl-32952656

Palavras-chave

PTPRZ1-MET fusion; glioma; immune response; risk score; secondary glioblastoma multiforme

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google